HL-300 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis

NCT07629778 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: HL-300
DRUG: Placebo
DRUG: HL-300
DRUG: HL-300

Sponsor

Hangzhou Highlightll Pharmaceutical Co., Ltd